Erik Spek

Erik oversees all corporate legal matters and leads Arrakis’ intellectual property strategy. He is an experienced biotech executive who has been a leader in corporate legal affairs and intellectual property for several biotech companies. Erik most recently served as Senior Vice President and Head of Legal Affairs and Intellectual Property at Vedanta Biosciences. At Vedanta, in addition to being responsible for all legal affairs, he developed a fundamental patent portfolio in the microbiome field and successfully defended a key European patent against multiple opponents. Prior to Vedanta, Erik served as Director of Intellectual Property for Epizyme, Inc. Previously, he worked as Boston-based IP law firm Wolf Greenfield, focusing on legal matters for a variety of bio and pharma related technologies. He earned his B.S. in Chemistry and Philosophy from Vrije Universiteit in Amsterdam. Dr. Spek received a J.D. from Suffolk Law School, a Ph.D. in biophysical chemistry from New York University, and conducted his postdoctoral research in biological engineering at MIT.